Kranzhöfer, R <br/><br/>
Systemic thrombin inhibition by Hirulog does not alter medial smooth muscle cell proliferation and inflammatory activation after vascular injury in the rabbit.  [electronic resource] 

 -  Cardiovascular drugs and therapy  Sep 1999 
 - 429-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0920-3206 
<br/><br/><label>Standard No.: </label>10.1023/a:1007808123953  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antithrombins--pharmacology<br/>Aorta, Abdominal--drug effects<br/>Blood Coagulation--drug effects<br/>Cell Division--drug effects<br/>Hirudins--analogs & derivatives<br/>Iliac Artery--drug effects<br/>Inflammation--pathology<br/>Intercellular Adhesion Molecule-1--drug effects<br/>Male<br/>Muscle, Smooth, Vascular--cytology<br/>Peptide Fragments--pharmacology<br/>Rabbits<br/>Recombinant Proteins--pharmacology<br/>Thrombin--antagonists & inhibitors